Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Arcturus Therapeutics Holdings (ARCT) Long-Term Debt Issuances (2021 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $15.0 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $15.0 million, compared with a TTM value of $15.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $15.0 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was $15.0 million for Q1 2025 at Arcturus Therapeutics Holdings, down from $46.6 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $46.6 million in Q1 2021 and bottomed at $15.0 million in Q1 2025.